
enVVeno Medical Corp
NVNO · NASDAQ · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Robert A. Berman
- Employees33
- Headquarters70 Doppler, Irvine, CA, United States, 92618, USA
- Websitehttps://www.envveno.com
Leadership
- Mr. Robert A. BermanCEO & Director · b. 1963
- Ms. Jennifer Bright CPAChief Financial Officer · b. 1971
- Dr. Hamed Alavi Ph.D.Senior VP & Chief Technology Officer · b. 1984
- Dr. Marc H. Glickman M.D.Senior VP & Chief Medical Officer · b. 1949
- Ms. Sandy PriettoVice President of Marketing
- Mr. Avi SharmaSenior Vice President of Clinical, Regulatory & Quality
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy1
Ownership Breakdown
- Institutions
- 15.96%
- Insiders
- 8.23%
- Retail / Other
- 75.81%
Top Institutional Holders
- Kingdon Capital Management LLC36.17K5.21%
- CM Management, LLC35.71K5.14%
- Geode Capital Management, LLC10.46K1.50%
- Vanguard Capital Management, LLC6.29K0.90%
- JPMorgan Chase & Co5.21K0.75%
- Vanguard Fiduciary Trust Co2.18K0.31%
- BlackRock Inc1.84K0.26%
- Westside Investment Management, Inc.1.52K0.22%
- Tower Research Capital LLC5420.08%
- Mirae Asset Global Investments (Korea) Co Ltd5390.08%
- UBS Group AG2430.04%
- Wells Fargo & Co1140.02%
- Allied Private Wealth LLC880.01%
- Vanguard Global Advisers, LLC770.01%
- Morgan Stanley - Brokerage Accounts760.01%
Top Fund Holders
- Fidelity Extended Market Index3.31K0.48%
- Fidelity Total Market Index8410.12%
- Fidelity Series Total Market Index8050.12%
- Fidelity Nasdaq Composite Index1760.03%
- Vanguard U.S. Eq Idx £ Acc770.01%
Stock Splits
- Jan 20, 20261:35
- Nov 30, 20201:25